NCT02544945

Brief Summary

This is a cohort study of 16 women undergoing post-mastectomy chest wall radiotherapy for breast cancer comparing two ways of modifying the radiation beam with bolus (a 5mm rubber substance placed on the skin to modify the radiation beam). The hypothesis is that 3D printed bolus will conform more closely to the chest wall than standard 5mm-thick standard bolus and thus lead to less chance of underdose or overdose of the skin. Each patient will receive the standard dose of radiotherapy, but half the treatments will use standard bolus and half the treatments will 3D printed bolus (ie each patient will act as is their own control). The primary outcome is the comparison of the amount of air under the bolus for each technique. Secondary outcome is the amount of time it takes to set up the patient for radiotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 9, 2015

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

January 31, 2019

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

July 20, 2015

Last Update Submit

January 29, 2019

Conditions

Keywords

Radiotherapy

Outcome Measures

Primary Outcomes (1)

  • Air gap under bolus

    Air gap is defined as a) the greatest distance from the skin to the bolus measured perpendicular to the chest wall, and b) the maximal area of skin underlying the maximal air pocket

    Up to 3 month

Secondary Outcomes (1)

  • Set up time

    Up to 3 months

Study Arms (2)

Standard Bolus

ACTIVE COMPARATOR

The radiotherapy treatment days when the standard bolus is used

Other: Standard bolus

3D printed bolus

EXPERIMENTAL

the radiotherapy treatment days when the 3D bolus is used

Other: 3D printed bolus

Interventions

Using the Cat Scan for treatment planning, a 3D plastic shell can be produced which is shaped exactly to the shape of the patient's chest wall. This shell will act as bolus - the substance that is placed on the skin during chest wall radiotherapy. The bolus allows the right dose of radiotherapy to get to the skin and the underlying chest wall.

3D printed bolus

A standard 5mm-thick piece of rubber is placed on the patient's chest wall

Standard Bolus

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women undergoing radiotherapy to the chest wall for the treatment of breast cancer with radical intent.

You may not qualify if:

  • Patients in whom the Radiation Oncologist plans to either omit bolus for more than half of the treatments (rarely happens).
  • Patients undergoing a non-standard chest-wall technique (eg. VMAT)
  • Pregnant or plans to get pregnant during radiotherapy
  • Inability to obtain informed consent or adhere to the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NSHA-QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 2Y9, Canada

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Robert DH Rutledge, MD

    Capital Health, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Staff Radiation Oncologist

Study Record Dates

First Submitted

July 20, 2015

First Posted

September 9, 2015

Study Start

January 1, 2016

Primary Completion

July 1, 2017

Study Completion

September 1, 2017

Last Updated

January 31, 2019

Record last verified: 2019-01

Locations